首页> 外文OA文献 >RAFT-Derived Polymethacrylates as a Superior Treatment for Recurrent Vulvovaginal Candidiasis by Targeting Biotic Biofilms and Persister Cells
【2h】

RAFT-Derived Polymethacrylates as a Superior Treatment for Recurrent Vulvovaginal Candidiasis by Targeting Biotic Biofilms and Persister Cells

机译:通过靶向生物膜和抗风细胞,筏衍生的聚甲基酸酯作为反复化外阴糖尿病患者的优异处理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundVulvovaginal candidiasis (VVC) is a common infection in need of more effective treatment. Formation of epithelium-associated Candida biofilms and the presence of persister cells are among the major contributing factors to the recurrence of this condition. We have previously developed RAFT-derived polymethacrylates that are effective in killing C. albicans biofilms in vitro. This study aimed to examine the clinical potential of polymethacrylates as antifungals for treatment of recurrent VVC (RVVC).MethodsA mouse model of VVC was used to establish vaginal epithelium-associated biofilms, using C. albicans isolates from VVC/RVVC patients. A comparison was made of the efficacies of polymethacrylates and conventional antifungals, clotrimazole and nystatin, in killing Candida in epithelium-associated biofilms in vivo. Ex vivo biofilms were used for Candida population profiling and to quantify persister cells in vaginal epithelia. The potency of polymethacrylates and conventional antifungals against persister cells, either as sole agents or in combination, was assessed.ResultsPolymethacrylates showed negligible local toxicity, resistance to vaginal acidity, and outstanding in vivo activity against vaginal epithelium-associated C. albicans biofilms. In vivo tests polymethacrylates outperformed the conventional antifungals, nystatin and clotrimazole at concentrations 50 times below the over-the-counter concentrations. Using polymethacrylates was associated with fewer persister cells, and better eradication of persister cells pre-selected by conventional antifungals.ConclusionThis study systematically assessed the clinical potential of RAFT-derived polymethacrylates as an effective treatment for VVC/RVVC in a mouse model. Polymethacrylates effectively killed vaginal epithelium-related C. albicans in vivo by specially targeting biotic biofilms and persister cells. Treatment presented negligible local toxicity.
机译:BackgroundVulvovaginal念珠病(VVC)是需要更有效的治疗方法的常见感染。上皮关联的念珠菌的形成和抗风肌细胞的存在是这种情况复发的主要因素。我们之前已经开发出筏衍生的聚甲酸酯,其在体外杀死C. albicans生物膜有效。该研究旨在研究聚甲基丙烯酸酯作为治疗复发性VVC(RVVC)的抗真菌药物的临床潜力。使用来自VVC / RVVC患者的C. albicans分离株,使用VVC的VVC的小鼠模型来建立阴道上皮蛋白相关的生物膜。甲比较了聚甲基丙烯酸酯和常规的抗真菌剂,克霉唑和制霉菌素的功效的,在体内上皮相关生物膜杀念珠菌。 exvivo生物膜用于念珠菌种群分析,并在阴道上皮细胞中量化泄漏细胞。评估聚甲基丙烯酸酯和常规抗真菌抗体的效力,作为唯一剂或组合。方法表明局部毒性可忽略不计,阴道酸度,抗视蛋白外膜相关的C. albicans Biofilms的阴道活性。在体内测试中,聚甲基丙烯酸酯优于常规抗真菌,Nystatin和Clotimazole,浓度低于过低浓度的50倍。通过常规使用antifungals.ConclusionThis聚甲基丙烯酸酯,用较少的持留细胞,和持留细胞更好消除相关联的预先选定的研究系统的评估RAFT衍生的聚甲基丙烯酸酯的临床潜力,在小鼠模型中的有效治疗VVC / RVVC。通过特别靶向生物膜和抗风细胞,聚甲基丙烯酸酯在体内有效地杀死了阴道上皮相关的C.醛醛醛醛糖苷。治疗局部毒性可忽略不计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号